Global Cord Blood Corporation Stock
Global Cord Blood Corporation Stock price
Key metrics
Is Global Cord Blood Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
Global Cord Blood Corporation Stock Analysis
Analyst Opinions
9 Analysts have issued a Global Cord Blood Corporation forecast:
Analyst Opinions
9 Analysts have issued a Global Cord Blood Corporation forecast:
Financial data from Global Cord Blood Corporation
| Mar '22 |
+/-
%
|
||
| Revenue | 173 173 |
7%
7%
|
|
| Gross Profit | 148 148 |
8%
8%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 85 85 |
12%
12%
|
| Net Profit | 70 70 |
1%
1%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Global Cord Blood Corporation directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. It preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
| Head office | Cayman Islands |
| CEO | Ting Zheng |
| Employees | 1,202 |
| Founded | 2008 |
| Website | globalcordbloodcorporation.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
